Current Research

Principle Investigator, Value of troponin in the Transgender population

Principle Investigator, Incident of stethoscope infections

Principle Investigator, Chest pain evaluation in the Emergency Department


Past Research

Principle Investigator, A randomized, double-blind, triple-dummy trial to compare the efficacy of otamixaban with Unfractionated Heparin + eptifibatide, in patients with Unstable angina/Non ST segment Elevation Myocardial infarction scheduled to undergo an early invasive strategy, sanofi-aventis U.S., Inc.

Principle Investigator, Natriuretic peptide testing for patients in renal failure receiving hemodialysis. Biosite Incorporated.

BEACON: Principal Investigator: Best Expert Agreement for Care of Occult MI Nationally (use of PRIME ECG technology)

CHAMPION: Principal Investigator: Phase III drug trial for cangrelor, a reversible P2Y12 antagonist for acute coronary syndromes.

Roche HDL-C: Principal Investigator. Phase III drug trial for dalcetrapib, a CETP inhibitor to reduce cardiovascular morbidity and mortality in stable CHD patients, with a documented recent ACS.

Principal Investigator. AMGEN RED-HF Phase III Drug Trial. To evaluate the efficacy, mortality and morbidity of darbepoeitan alpha in patients with heart failure.

Principal Investigator. Determine the impact of cardiac bedside multimarker testing in the emergency department on draw time to decision making (DD), turnaround time (TAT), and correlation of results between central laboratory, Biosite, and Ramp.

VAMPIRE. To determine the extent of variability of BNP measurements in patients followed in cardiology clinics as a function of stability, improvement, and decompensation

AFFECTS. To examine the consistency of physician practice patterns of atrial fibrillation in accordance with ACC/AHA/ESC guidelines.

Principal Investigator. Audicore S3. To determine the prevalence and changes of heart sounds in patients who present to ED with CHF and the correlation with BNP.

Principal Investigator. HD/BNP. Determining the role of BNP when evaluating cardiac dysfunction in patients on hemodialysis.

Principal Investigator. Rapid Point Coagulation ENOX test in patient with altered Pharmacokinetics of Enoxaparin

Principal Investigator(site). P.L.A.C.E. Proving (Cardizem LA) LA through Clinical Experience. (National-Multicenter)

Principal Investigator(site). SYNERGY Study in high-risk patients presenting with Non ST-Segment Elevation Acute Coronary Syndromes, managed primarily with an early invasive strategy with cardiac catherization (International-Multicenter)

Principal Investigator(site). DTI-009 Ventricular rate control in adult patients with Atrial Fibrillation. (National-Multicenter)

Principal Investigator(site). Corlopam Trial evaluating the safety, efficacy and tolerability of Fendolopam Mesylate in subjects undergoing diagnostic and/or interventional cardiology procedures who are at risk for developing RCN. (National-Multicenter)

Principal Investigator(site). T.R.E.A.T. Telithromycin Respiratory Effectiveness Assessment Trial. (National-Multicenter)

Principal Investigator(site). P.E.A.C.E. Prevention of Events with Angiotensin Converting Enzyme Inhibition. (National-Multicenter)

Principal Investigator(site). ASSENT 3 Study Assessing the safety and efficacy of a new thrombolytic agent: Tnk-tPA Phase III (Multicenter)

Principal Investigator(site). OCTAVE Omapatrilat Cardiovascular Treatment Assessment Versus Enalapril. (National-Multicenter)

Co-Investigator, BOW TIE Study in correlating rapid assays and quantitative blood tests (International, Multicenter)

Principal Investigator(site), EndiCOR X-Tract “X-SIZER” Phase II Study (Multicenter)

Principal Investigator, Now Evaluate Chest Pain with the Aid of Rapid Assays and ECG for Diagnosis of Chest Pain in the Ambulance (NEW ERA) Study – Phases I, Ib and II

Principal Investigator(site), Evaluation of Oral Xemilofiban in Controlling Thrombotic Events (EXCITE) Trial (Multicenter)

Principal Investigator(site), Percutaneous Transmyocardial Revascularization for severe Unstable Angina (Multicenter)

Principal Investigator, Rapid Evaluation of Chest Pain In The Emergency Department Phase I, Completed, follow up in progress

Principal Investigator, Rapid Evaluation of Chest Pain In The Emergency Department Phase II, completed, follow-up in progress

Principal Investigator, Pre-Arrest Scoring and Outcome of CPR

Co-Investigator(site), Comparison of safety and efficacy of CABG Alone and TMR and CABG (Multicenter)

Co-Investigator(site), MIDCAB alone versus TMR and MIDCAB (Multicenter)

Co-Investigator(site), Holmium Laser Angioplasty of Restenosis of Coronary Stent (Multicenter)

Principal Investigator(site), National Registry of Acute Myocardial Infarction (NRMI) II and II (Multicenter Study)

Co-Investigator, Patency of Palmaz Stents in Peripheral Vascular Disease

Co-Investigator, Long term result of Laser- Assisted Balloon Angioplasty of Peripheral Vascular Disease

Co-Investigator, Patency of Wallstent in Saphenous Vein Bypass Graft

Co-Investigator, Patency of Palmaz-Schatz Stent in Saphenous Vein Bypass Graft

Co-Investigator, Patency of Wallstent in Iliac and Femoropopliteal Arterial Disease

Co-Investigator, Palmaz-Schatz Stent in Renal Arterial Disease

Co-Investigator (site), “PEAK” new Coronary Angioplasty Balloon Study from AVE